{"count": 3, "results": [{"_id": "37119382", "pmid": 37119382, "title": "Metformin attenuates sevoflurane-induced neurogenesis damage and cognitive impairment: involvement of the Nrf2/G6PD pathway.", "journal": "Metab Brain Dis", "authors": ["Fan P", "Lu Y", "Wei H", "Wang K", "Jia P", "Zhang Y", "Zhang Y", "Wang T", "Yang L", "Zhao J", "Zhang S", "Lu H", "Chen X", "Liu Y", "Zhang P"], "date": "2023-04-29T00:00:00Z", "doi": "10.1007/s11011-023-01218-2", "meta_date_publication": "2023 Apr 29", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50258.7, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ attenuates @CHEMICAL_Sevoflurane @CHEMICAL_MESH:D000077149 @@@sevoflurane@@@-induced @<m>DISEASE_Urinary_Bladder_Neurogenic</m> @DISEASE_MESH:D001750 @@@neurogenesis damage@@@ and @DISEASE_Cognition_Disorders @DISEASE_MESH:D003072 @@@cognitive impairment@@@: involvement of the @GENE_NFE2L2 @GENE_83619 @@@Nrf2@@@/@GENE_G6PD @GENE_24377 @@@G6PD@@@ pathway.", "citations": {"NLM": "Fan P, Lu Y, Wei H, Wang K, Jia P, Zhang Y, Zhang Y, Wang T, Yang L, Zhao J, Zhang S, Lu H, Chen X, Liu Y, Zhang P. Metformin attenuates sevoflurane-induced neurogenesis damage and cognitive impairment: involvement of the Nrf2/G6PD pathway. Metab Brain Dis. 2023 Apr 29;():. PMID: 37119382", "BibTeX": "@article{37119382, title={Metformin attenuates sevoflurane-induced neurogenesis damage and cognitive impairment: involvement of the Nrf2/G6PD pathway.}, author={Fan P and Lu Y and Wei H and Wang K and Jia P and Zhang Y and Zhang Y and Wang T and Yang L and Zhao J and Zhang S and Lu H and Chen X and Liu Y and Zhang P}, journal={Metab Brain Dis}}"}}, {"_id": "36561946", "pmid": 36561946, "pmcid": "PMC9764204", "title": "A concealed history behind the disaster: Extremely rare presentations of metformin toxicity in a patient with body dysmorphic disorder", "journal": "Toxicol Rep", "authors": ["Hajsadeghi S", "Gholizadeh Mesgarha M", "Pour Mohammad A", "Saberi Shahrbabaki A", "Talebi A"], "date": "2022-04-12T00:00:00Z", "doi": "10.1016/j.toxrep.2022.04.004", "meta_date_publication": "2022", "meta_volume": "9", "meta_issue": "", "meta_pages": "848-851", "score": 50248.066, "text_hl": "We presented here a case of a 36-year-old @SPECIES_9606 @@@woman@@@ who developed several presentations with diverse features during three years comprising @<m>DISEASE_Urinary_Bladder_Neurogenic</m> @DISEASE_MESH:D001750 @@@neuropathic symptoms@@@, severe @DISEASE_Acidosis_Lactic @DISEASE_MESH:D000140 @@@lactic acidosis@@@, three episodes of @DISEASE_Shock_Cardiogenic @DISEASE_MESH:D012770 @@@cardiogenic shock@@@, @DISEASE_Acute_Kidney_Injury @DISEASE_MESH:D058186 @@@acute kidney injury@@@, @DISEASE_Anemia_Megaloblastic @DISEASE_MESH:D000749 @@@megaloblastic anemia@@@, @DISEASE_Pancytopenia @DISEASE_MESH:D010198 @@@pancytopenia@@@, and @DISEASE_Hyponatremia @DISEASE_MESH:D007010 @@@hyponatremia@@@ and did not receive a definite diagnosis after each presentation until when she inadvertently disclosed her abuse of extremely unusual doses of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ during these three years with aim of @DISEASE_Weight_Loss @DISEASE_MESH:D015431 @@@weight reduction@@@ obsessively without knowing that her symptoms could pertain to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ @DISEASE_Drug_Overdose @DISEASE_MESH:D062787 @@@overdose@@@. ", "citations": {"NLM": "Hajsadeghi S, Gholizadeh Mesgarha M, Pour Mohammad A, Saberi Shahrbabaki A, Talebi A. A concealed history behind the disaster: Extremely rare presentations of metformin toxicity in a patient with body dysmorphic disorder Toxicol Rep. 2022;9():848-851. PMID: 36561946", "BibTeX": "@article{36561946, title={A concealed history behind the disaster: Extremely rare presentations of metformin toxicity in a patient with body dysmorphic disorder}, author={Hajsadeghi S and Gholizadeh Mesgarha M and Pour Mohammad A and Saberi Shahrbabaki A and Talebi A}, journal={Toxicol Rep}, volume={9}, pages={848-851}}"}}, {"_id": "39796218", "pmid": 39796218, "title": "Mitochondria and the Repurposing of Diabetes Drugs for Off-Label Health Benefits.", "journal": "Int J Mol Sci", "authors": ["Yip JMX", "Chiang GSH", "Lee ICJ", "Lehming-Teo R", "Dai K", "Dongol L", "Wang LY", "Teo D", "Seah GT", "Lehming N"], "date": "2025-01-03T00:00:00Z", "doi": "10.3390/ijms26010364", "meta_date_publication": "2025 Jan 3", "meta_volume": "26", "meta_issue": "1", "meta_pages": "", "score": 50245.863, "text_hl": "This review describes our current understanding of the role of the mitochondria in the repurposing of the anti-@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes drugs@@@ @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, @CHEMICAL_Gliclazide @CHEMICAL_MESH:D005907 @@@gliclazide@@@, @GENE_GLP1R @GENE_2740 @@@GLP-1 receptor@@@ agonists, and SGLT2 inhibitors for additional clinical benefits regarding unhealthy aging, @DISEASE_Post_Acute_COVID_19_Syndrome @DISEASE_MESH:D000094024 @@@long COVID@@@, @DISEASE_Intellectual_Disability @DISEASE_MESH:D008607 @@@mental@@@ @<m>DISEASE_Urinary_Bladder_Neurogenic</m> @DISEASE_MESH:D001750 @@@neurogenerative disorders@@@, and @DISEASE_Obesity @DISEASE_MESH:D009765 @@@obesity@@@. ", "citations": {"NLM": "Yip JMX, Chiang GSH, Lee ICJ, Lehming-Teo R, Dai K, Dongol L, Wang LY, Teo D, Seah GT, Lehming N. Mitochondria and the Repurposing of Diabetes Drugs for Off-Label Health Benefits. Int J Mol Sci. 2025 Jan 3;26(1):. PMID: 39796218", "BibTeX": "@article{39796218, title={Mitochondria and the Repurposing of Diabetes Drugs for Off-Label Health Benefits.}, author={Yip JMX and Chiang GSH and Lee ICJ and Lehming-Teo R and Dai K and Dongol L and Wang LY and Teo D and Seah GT and Lehming N}, journal={Int J Mol Sci}, volume={26}, number={1}}"}}]}